Clinical Trials Browser

Phase 1 × OTHER × salicylsalicylic acid × Clear all

NCT01489319 2017-02-10

ELI-ROAS

Phase 1 Terminated

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism